{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T10:05:20Z","timestamp":1787652320975,"version":"build-2736575974"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T00:00:00Z","timestamp":1766102400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000266","name":"Engineering and Physical Sciences Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000266","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002873","name":"Chulalongkorn University","doi-asserted-by":"publisher","award":["HEA663000045"],"award-info":[{"award-number":["HEA663000045"]}],"id":[{"id":"10.13039\/501100002873","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000276","name":"Department of Health and Social Care","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000276","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017170","name":"Thailand Science Research and Innovation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100017170","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100031580","name":"National Vaccine Institute","doi-asserted-by":"publisher","award":["2568.1\/5"],"award-info":[{"award-number":["2568.1\/5"]}],"id":[{"id":"10.13039\/100031580","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","award":["INV-080661"],"award-info":[{"award-number":["INV-080661"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.vaccine.2025.128099","type":"journal-article","created":{"date-parts":[[2025,12,25]],"date-time":"2025-12-25T07:17:13Z","timestamp":1766647033000},"page":"128099","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["mRNA vaccines targeting Leptospira immunoglobulin-like proteins confer partial protection in a hamster model of leptospirosis"],"prefix":"10.1016","volume":"73","author":[{"given":"Teerasit","family":"Techawiwattanaboon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ratikarn","family":"Leekitcharoenphon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamad-Gabriel","family":"Alameh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sukon","family":"Boonkea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nuttapone","family":"Sangkanjanavanich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaowarin","family":"Nakornpakdee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yada","family":"Ajimathorn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eakachai","family":"Prompetchara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chutitorn","family":"Ketloy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Supranee","family":"Buranapraditkun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanapat","family":"Palaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sakawrat","family":"Kanthawong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Heyes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Drew","family":"Weissman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiat","family":"Ruxrungtham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kanitha","family":"Patarakul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2025.128099_bb0005","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0003898","article-title":"Global morbidity and mortality of leptospirosis: a systematic review","volume":"9","author":"Costa","year":"2015","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.vaccine.2025.128099_bb0010","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0003843","article-title":"Environmental and behavioural determinants of leptospirosis transmission: a systematic review","volume":"9","author":"Mwachui","year":"2015","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.vaccine.2025.128099_bb0015","first-page":"65","article-title":"Leptospirosis in humans","volume":"387","author":"Haake","year":"2015","journal-title":"Curr Top Microbiol Immunol"},{"key":"10.1016\/j.vaccine.2025.128099_bb0020","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.2217\/fmb.10.102","article-title":"Leptospira as an emerging pathogen: a review of its biology, pathogenesis and host immune responses","volume":"5","author":"Evangelista","year":"2010","journal-title":"Future Microbiol"},{"key":"10.1016\/j.vaccine.2025.128099_bb0025","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0007270","article-title":"Revisiting the taxonomy and evolution of pathogenicity of the genus Leptospira through the prism of genomics","volume":"13","author":"Vincent","year":"2019","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.vaccine.2025.128099_bb0030","first-page":"139","article-title":"The molecular basis of leptospiral pathogenesis","volume":"387","author":"Murray","year":"2015","journal-title":"Curr Top Microbiol Immunol"},{"key":"10.1016\/j.vaccine.2025.128099_bb0035","first-page":"251","article-title":"Vaccines against leptospirosis","volume":"387","author":"Adler","year":"2015","journal-title":"Curr Top Microbiol Immunol"},{"key":"10.1016\/j.vaccine.2025.128099_bb0040","doi-asserted-by":"crossref","DOI":"10.1111\/sji.13316","article-title":"Human leptospirosis: in search for a better vaccine","volume":"98","author":"Azevedo","year":"2023","journal-title":"Scand J Immunol"},{"key":"10.1016\/j.vaccine.2025.128099_bb0045","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1080\/17460441.2020.1694508","article-title":"An overview of human leptospirosis vaccine design and future perspectives","volume":"15","author":"Felix","year":"2020","journal-title":"Expert Opin Drug Discovery"},{"key":"10.1016\/j.vaccine.2025.128099_bb0050","doi-asserted-by":"crossref","first-page":"6277","DOI":"10.1016\/j.vaccine.2007.05.053","article-title":"The terminal portion of leptospiral immunoglobulin-like protein LigA confers protective immunity against lethal infection in the hamster model of leptospirosis","volume":"25","author":"Silva","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2025.128099_bb0055","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0001422","article-title":"A LigA three-domain region protects hamsters from lethal infection by Leptospira interrogans","volume":"5","author":"Coutinho","year":"2011","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.vaccine.2025.128099_bb0060","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0180004","article-title":"Immunoprotective properties of recombinant LigA and LigB in a hamster model of acute leptospirosis","volume":"12","author":"Evangelista","year":"2017","journal-title":"PloS One"},{"key":"10.1016\/j.vaccine.2025.128099_bb0065","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0005441","article-title":"LigB subunit vaccine confers sterile immunity against challenge in the hamster model of leptospirosis","volume":"11","author":"Conrad","year":"2017","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.vaccine.2025.128099_bb0070","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.vaccine.2008.10.089","article-title":"Leptospira immunoglobulin-like protein a variable region (LigAvar) incorporated in liposomes and PLGA microspheres produces a robust immune response correlating to protective immunity","volume":"27","author":"Faisal","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2025.128099_bb0075","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2022.918629","article-title":"Designing adjuvant formulations to promote immunogenicity and protective efficacy of Leptospira immunoglobulin-like protein a subunit vaccine","volume":"12","author":"Techawiwattanaboon","year":"2022","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.vaccine.2025.128099_bb0080","first-page":"11","article-title":"Leptospira lipid a is a potent adjuvant that induces sterilizing immunity against leptospirosis","author":"Varma","year":"2023","journal-title":"Vaccines (Basel)."},{"key":"10.1016\/j.vaccine.2025.128099_bb0085","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.micinf.2008.11.008","article-title":"Immunogenicity and protective efficacy of recombinant Leptospira immunoglobulin-like protein B (rLigB) in a hamster challenge model","volume":"11","author":"Yan","year":"2009","journal-title":"Microbes Infect"},{"key":"10.1016\/j.vaccine.2025.128099_bb0090","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.985802","article-title":"LigA formulated in AS04 or Montanide ISA720VG induced superior immune response compared to alum, which correlated to protective efficacy in a hamster model of leptospirosis","volume":"13","author":"Varma","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.vaccine.2025.128099_bb0095","article-title":"Reduced Renal Colonization and Enhanced Protection by Leptospiral Factor H Binding Proteins as a Multisubunit Vaccine Against Leptospirosis in Hamsters","volume":"7","author":"Techawiwattanaboon","year":"2019","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.vaccine.2025.128099_bb0100","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1128\/CVI.00285-15","article-title":"Protective immunity and reduced renal colonization induced by vaccines containing recombinant Leptospira interrogans outer membrane proteins and flagellin adjuvant","volume":"22","author":"Monaris","year":"2015","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2025.128099_bb0105","series-title":"Dellagostin OA","first-page":"12","author":"de Oliveira","year":"2023"},{"key":"10.1016\/j.vaccine.2025.128099_bb0110","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1038\/s41573-021-00283-5","article-title":"mRNA vaccines for infectious diseases: principles, delivery and clinical translation","volume":"20","author":"Chaudhary","year":"2021","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.vaccine.2025.128099_bb0115","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/1472-6750-10-77","article-title":"Intranasal vaccination with messenger RNA as a new approach in gene therapy: use against tuberculosis","volume":"10","author":"Lorenzi","year":"2010","journal-title":"BMC Biotechnol"},{"key":"10.1016\/j.vaccine.2025.128099_bb0120","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1016\/j.omtn.2019.12.044","article-title":"Strong immune responses induced by direct local injections of modified mRNA-lipid nanocomplexes","volume":"19","author":"Arya","year":"2020","journal-title":"Mol Ther Nucleic Acids"},{"key":"10.1016\/j.vaccine.2025.128099_bb0125","doi-asserted-by":"crossref","first-page":"eadg1036","DOI":"10.1126\/sciadv.adg1036","article-title":"A single-dose F1-based mRNA-LNP vaccine provides protection against the lethal plague bacterium","volume":"9","author":"Kon","year":"2023","journal-title":"Sci Adv"},{"key":"10.1016\/j.vaccine.2025.128099_bb0130","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1038\/s41541-023-00672-4","article-title":"Strong immune responses and protection of PcrV and OprF-I mRNA vaccine candidates against Pseudomonas aeruginosa","volume":"8","author":"Wang","year":"2023","journal-title":"NPJ Vaccines"},{"key":"10.1016\/j.vaccine.2025.128099_bb0135","doi-asserted-by":"crossref","first-page":"2702","DOI":"10.1016\/j.ymthe.2023.07.022","article-title":"Development of an mRNA-lipid nanoparticle vaccine against Lyme disease","volume":"31","author":"Pine","year":"2023","journal-title":"Mol Ther"},{"key":"10.1016\/j.vaccine.2025.128099_bb0140","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1126\/science.adn4955","article-title":"A multivalent mRNA-LNP vaccine protects against Clostridioides difficile infection","volume":"386","author":"Alameh","year":"2024","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2025.128099_bb0145","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/S0006-291X(02)00566-1","article-title":"Human secretory signal peptide description by hidden Markov model and generation of a strong artificial signal peptide for secreted protein expression","volume":"294","author":"Barash","year":"2002","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.vaccine.2025.128099_bb0150","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1016\/j.ymthe.2020.04.018","article-title":"A multi-targeting, nucleoside-modified mRNA influenza virus vaccine provides broad protection in mice","volume":"28","author":"Freyn","year":"2020","journal-title":"Mol Ther"},{"key":"10.1016\/j.vaccine.2025.128099_bb0155","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.1038\/s41467-023-37795-0","article-title":"Immunogenicity and protective efficacy of SARS-CoV-2 mRNA vaccine encoding secreted non-stabilized spike in female mice","volume":"14","author":"Prompetchara","year":"2023","journal-title":"Nat Commun"},{"key":"10.1016\/j.vaccine.2025.128099_bb0160","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.omtn.2019.02.018","article-title":"A facile method for the removal of dsRNA contaminant from in vitro-transcribed mRNA","volume":"15","author":"Baiersdorfer","year":"2019","journal-title":"Mol Ther Nucleic Acids."},{"key":"10.1016\/j.vaccine.2025.128099_bb0165","article-title":"Lipid nanoparticle formulations","volume":"WO2020097540A1","author":"Heyes","year":"2020","journal-title":"World Intellectual Property Organization (WIPO)"},{"key":"10.1016\/j.vaccine.2025.128099_bb0170","first-page":"9","article-title":"Nanomaterial delivery systems for mRNA vaccines","author":"Buschmann","year":"2021","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.vaccine.2025.128099_bb0175","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0009983","article-title":"Surface proteomics and label-free quantification of Leptospira interrogans serovar Pomona","volume":"15","author":"Techawiwattanaboon","year":"2021","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.vaccine.2025.128099_bb0180","unstructured":"Zuerner R.L. Laboratory maintenance of pathogenic Leptospira. Curr Protoc Microbiol. 2005. Chapter 12:Unit 12E 1. 12E.1.1-12E.1.13."},{"key":"10.1016\/j.vaccine.2025.128099_bb0185","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0248007","article-title":"DNA vaccine candidate encoding SARS-CoV-2 spike proteins elicited potent humoral and Th1 cell-mediated immune responses in mice","volume":"16","author":"Prompetchara","year":"2021","journal-title":"PloS One"},{"key":"10.1016\/j.vaccine.2025.128099_bb0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbrc.2024.151229","article-title":"In silico prediction and experimental evaluation of LIP3228 of pathogenic Leptospira as a potential subunit vaccine target against leptospirosis","volume":"745","author":"Nakornpakdee","year":"2025","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.vaccine.2025.128099_bb0195","first-page":"6","article-title":"Extended low-resolution structure of a Leptospira antigen offers high bactericidal antibody accessibility amenable to vaccine design","author":"Hsieh","year":"2017","journal-title":"Elife"},{"key":"10.1016\/j.vaccine.2025.128099_bb0200","article-title":"Leptospiral immunoglobulin-like domain proteins: roles in virulence and immunity","volume":"11","author":"Haake","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.vaccine.2025.128099_bb0205","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1099\/00222615-11-4-387","article-title":"The antibodies involved in the human immune response to leptospiral infection","volume":"11","author":"Adler","year":"1978","journal-title":"J Med Microbiol"},{"key":"10.1016\/j.vaccine.2025.128099_bb0210","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1016\/j.immuni.2022.05.007","article-title":"Lipid nanoparticles enhance the efficacy of mRNA and protein subunit vaccines by inducing robust T follicular helper cell and humoral responses","volume":"55","author":"Alameh","year":"2022","journal-title":"Immunity"},{"key":"10.1016\/j.vaccine.2025.128099_bb0215","doi-asserted-by":"crossref","DOI":"10.1016\/j.sbi.2022.102348","article-title":"Glycosylation as a key parameter in the design of nucleic acid vaccines","volume":"73","author":"Ozdilek","year":"2022","journal-title":"Curr Opin Struct Biol"},{"key":"10.1016\/j.vaccine.2025.128099_bb0220","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1093\/infdis\/jir875","article-title":"Leptospiral immunoglobulin-like proteins interact with human complement regulators factor H, FHL-1, FHR-1, and C4BP","volume":"205","author":"Castiblanco-Valencia","year":"2012","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2025.128099_bb0225","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.imlet.2016.03.005","article-title":"Acquisition of negative complement regulators by the saprophyte Leptospira biflexa expressing LigA or LigB confers enhanced survival in human serum","volume":"173","author":"Castiblanco-Valencia","year":"2016","journal-title":"Immunol Lett"},{"key":"10.1016\/j.vaccine.2025.128099_bib232","first-page":"111","article-title":"Antigens recognized by the human immune response to vaccination with a bivalent hardjo\/pomona leptospiral vaccine","volume":"2","author":"Chapman","year":"1990","journal-title":"FEMS Microbiol Immunol"},{"key":"10.1016\/j.vaccine.2025.128099_bib233","doi-asserted-by":"crossref","first-page":"2441","DOI":"10.1128\/IAI.01635-06","article-title":"Physiological osmotic induction of Leptospira interrogans adhesion: LigA and LigB bind extracellular matrix proteins and fibrinogen","volume":"75","author":"Choy","year":"2007","journal-title":"Infect Immun"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X25013970?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X25013970?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T09:04:35Z","timestamp":1770282275000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X25013970"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":47,"alternative-id":["S0264410X25013970"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2025.128099","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"mRNA vaccines targeting Leptospira immunoglobulin-like proteins confer partial protection in a hamster model of leptospirosis","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2025.128099","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"128099"}}